Back
Biogen, Inc. Vs. Nuvalent, Inc. Industry Stock Comparison
Buy
56
BIIB
Biogen, Inc.
Last Price:
$181.35
Seasonality Move:
9.63%
Sell
48
NUVL
Nuvalent, Inc.
Last Price:
$109.73
Seasonality Move:
-9.12%
Buy
56
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $181.30. The Score for BIIB is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Nuvalent, Inc. (NUVL)
is a Sell
Is Nuvalent, Inc. a Buy, Sell or Hold?
-
The current Nuvalent, Inc. [NUVL] share price is $109.60. The Score for NUVL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $181.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing selling pressure, which indicates risk of future bearish movement.
NUVL Stock Price Chart
What is Nuvalent, Inc.'s stock price today?
-
The Nuvalent, Inc. share price today is $109.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUVL is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.6 | Buy |
| Relative Strength Index (14 RSI): | 71.96 | Buy |
| Chaikin Money Flow: | -973313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (156.9 - 179.1) | Buy |
| Bollinger Bands (100): | (131.57 - 161.99) | Buy |
NUVL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.76 | Buy |
| Relative Strength Index (14 RSI): | 62.32 | Buy |
| Chaikin Money Flow: | 367706 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (95.22 - 108.6) | Buy |
| Bollinger Bands (100): | (76.14 - 98.08) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181 | Buy |
| 20-day SMA: | 171.74 | Buy |
| 50-day SMA: | 157.9 | Buy |
| 200-day SMA: | 138.45 | Buy |
| 8-day EMA: | 179.45 | Buy |
| 20-day EMA: | 172.57 | Buy |
| 50-day EMA: | 161.06 | Buy |
| 200-day EMA: | 149.88 | Buy |
NUVL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.88 | Buy |
| 20-day SMA: | 103.82 | Buy |
| 50-day SMA: | 95.93 | Buy |
| 200-day SMA: | 80.76 | Buy |
| 8-day EMA: | 107.34 | Buy |
| 20-day EMA: | 104.3 | Buy |
| 50-day EMA: | 97.28 | Buy |
| 200-day EMA: | 85.55 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.12 per share.
Nuvalent, Inc. Earnings Growth & NUVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.77 per share, and a decrease next year of $0.13 per share.
Biogen, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nuvalent, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||